6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 26 May 2026
- Reporting date
- 26 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,780 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 26-50 of 1,000 matching filings.
Per page
25
Current page
2
6-K
File 001-15170
Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026
- Filing date
- 22 May 2026
- Reporting date
- 22 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 20 May 2026
- Reporting date
- 20 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 20 May 2026
- Reporting date
- 20 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 19 May 2026
- Reporting date
- 19 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 18 May 2026
- Reporting date
- 18 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR
- Filing date
- 18 May 2026
- Reporting date
- 18 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-HR
File 028-26280
13F-HR filing
- Filing date
- 14 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 14 May 2026
- Reporting date
- 14 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 11 May 2026
- Reporting date
- 11 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN
- Filing date
- 11 May 2026
- Reporting date
- 11 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME
- Filing date
- 11 May 2026
- Reporting date
- 11 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RESULT OF AGM
- Filing date
- 06 May 2026
- Reporting date
- 06 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G
File 005-84251
SCHEDULE 13G filing
- Filing date
- 06 May 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 May 2026
- Reporting date
- 05 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 May 2026
- Reporting date
- 01 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 01 May 2026
- Reporting date
- 01 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 29 Apr 2026
- Reporting date
- 29 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
1ST QUARTER RESULTS
- Filing date
- 29 Apr 2026
- Reporting date
- 29 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Apr 2026
- Reporting date
- 28 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCE
- Filing date
- 28 Apr 2026
- Reporting date
- 28 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONS
- Filing date
- 27 Apr 2026
- Reporting date
- 27 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TESARO UPDATE ON ANAPTYSBIO INC. LITIGATION
- Filing date
- 27 Apr 2026
- Reporting date
- 27 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Apr 2026
- Reporting date
- 24 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 23 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing